A three-judge panel on Jan. 4 revived a lawsuit against five pharma companies accused of helping finance terror attacks against U.S. service members in Iraq during the “War on Terror.”

“A 2017 lawsuit alleging five pharmaceutical companies helped finance terror attacks against U.S. service members and other Americans in Iraq during the “War on Terror” was unanimously reinstated and remanded by a three-judge panel of the D.C. Court of Appeals.

The lawsuit against the five companies in question — Pfizer, AstraZeneca, Johnson & Johnson, Roche and GE Healthcare — was dismissed in July 2020 by a federal district court in Washington, D.C. before being reinstated last week.

The lawsuit claims the five companies regularly paid bribes, including free drugs and medical devices, to officials in Iraq’s Ministry of Health between 2005 and 2011, in their efforts to secure drug contracts.

In turn, the suit alleges, these companies’ contracts with the Iraqi health ministry helped “fund terrorism” perpetrated by a Shiite militia that killed Americans during that period.”

https://childrenshealthdefense.org/defender/pfizer-johnson-pharma-funding-terrorism-iraq/?